Pembrolizumab-induced Guillain-Barré syndrome in triple-negative breast cancer: A case report
Pembrolizumab can induce GBS, necessitating early recognition, prompt diagnosis, and multidisciplinary management to prevent serious complications.
Authors
- Sai Rakshith Gaddameedi
- Muhammad Tayyeb (ORCID: https://orcid.org/0000-0002-6282-1133)
- Doantrang Du
- Phani Bhavana Cherukuri
- Trishala Meghal
Institutions
- Monmouth Medical Center (US)
Publication Details
- Journal
- World Journal of Clinical Oncology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.5306/wjco.v16.i2.97823
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.57